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Abstract The Clinical Electro-oculogram
(EOG) is an electrophysiological test of function
of the outer retina and retinal pigment epithelium
(RPE) in which the change in the electrical
potential between the cornea and the ocular
fundus is recorded during successive periods of
dark and light adaptation. This document sets out
a Standard Method for performance of the test,
and also gives detailed guidance on technical and
practical issues, and on reporting test results. The
main object of the Standard is to promote
consistent quality of testing and reporting within
and between centres. This 2006 Standard, from
the International Society for Clinical Electro-
physiology of Vision (ISCEV: www.iscev.org ), is
a revision of the previous Standard published in
1993, and reviewed and re-issued in 1998.
Keywords Arden ratio  Clinical standards 
Electro-oculogram  Light adaptation  Retinal
pigment epithelium
Abbreviations
ERG Electroretinogram
FO Fast oscillation
RPE Retinal pigment epithelium
Purpose and use of this Standard
This Standard is one of a series of Standards and
Guidelines for electrophysiology of vision [1–8]
available for download from www.iscev.org, and
is a revision of the ISCEV Standard for Clinical
Electro-oculography (ﬁrst issued 1993 – re-
approved 1998) [1, 2], which provides a Standard
Method for measurement of the electro-oculo-
gram (EOG). Also included is advice on possible
variations on the Standard Method, additional
tests, and comment on the procedures recom-
mended. The major change in this current
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dards is that it recommends one single standard
testing protocol and measurement strategy.
Clinical and research users of the clinical EOG
are encouraged to use the current Standard
Method where possible, to achieve consistency
of results within and between test centres.
Reports of EOG recordings performed to the
Standard Method given here should cite this 2006
Standard. Where a method is used which deviates
from the Standard Method, the deviations should
be stated, together with any normative or refer-
ence data. Where the method used conforms to a
previous EOG Standard, this may be cited
instead.
EOG origins, pathological effects, and principles
of measurement
Electrophysiology of the RPE in dark and
light adaptation
The eye has a standing electrical potential
between front and back, sometimes called the
corneo-fundal potential. The potential is mainly
derived from the retinal pigment epithelium
(RPE), and it changes in response to retinal
illumination. The potential decreases for 8–
10 min in darkness. Subsequent retinal illumi-
nation causes an initial fall in the standing
potential over 60–75 s (the fast oscillation
(FO)), followed by a slow rise for 7–14 min
(the light response). These phenomena arise
from ion permeability changes across the basal
RPE membrane. The clinical electro-oculogram
(EOG) makes an indirect measurement of the
minimum amplitude of the standing potential in
the dark and then again at its peak after the
light rise. This is usually expressed as a ratio of
‘light peak to dark trough’ and referred to as
the Arden ratio. The behaviour of the corneo-
fundal potential in the normal eye is predictable
in deﬁned conditions, such as those described in
this Standard, but changing from dark to light
actually initiates a triggered response extending
for about 2 h in the form of a diminishing sinusoi-
dal oscillation.
Diseases affecting the light response of the
EOG
The light response is affected in diffuse disorders
of the RPE and the photoreceptor layer of the
retina including some characterised by rod dys-
function, or chorio-retinal atrophic and inﬂam-
matory diseases. In most of these there is
correlation with the electroretinogram (ERG),
except notably in the case of Best’s vitelliform
maculopathy, in which the clinical EOG is usually
highly abnormal in the presence of a normal
ERG.
Measurement of the clinical EOG
The potential across the RPE causes the front of
the eye to be electrically positive compared to the
back. As a result, potentials measured between
two electrodes placed on the skin at each side of
an eye will change as the eye turns from left to
right. The EOG method is used widely to record
eye movements, on the assumption of unchanging
corneo-fundal potentials. In the clinical EOG
described here, we use deﬁned eye movements to
monitor the changes in corneo-fundal potential. If
the test subject looks alternately at targets a ﬁxed
angle apart, the potential recorded from the skin
resembles a square wave whose amplitude will be
a ﬁxed proportion of the corneo-fundal potential.
During a light/dark cycle, this indirectly measured
potential will change in the same way as the
source potentials, so that the Arden ratios (and
timing of peaks etc.) will be a close approxima-
tion to the average changes occurring across the
RPE.
The Standard Method
This section outlines the Standard Clinical
EOG method, deﬁnitions, explanations, and
instrument speciﬁcations. Further notes
regarding testing strategies are given in later
sections.
Pupils Apply dilating drops before any other
action to allow pupil dilation to be relatively
complete by the start of the test (see notes
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123below). Their size should be checked at the start
and end of the test and recorded at the end of the
test.
Electrodes After suitable skin preparation,
place small recording electrodes, close to the
canthi of each eye as in Fig. 1. Connect the
electrodes from each eye to separate channels of
a differential ampliﬁer. The ‘ground’ electrode
can be placed on the forehead. The impedance
between any pair of electrodes should not exceed
5k W. The electrodes, ampliﬁer and impedance
meter must be approved for medical use.
Ampliﬁer This should have a band pass of
either 0 (d.c.) to 30 Hz, or 0.1 to 30 Hz, to provide
recordings of the saccades which appear as square
waves.
Full ﬁeld (Ganzfeld) stimulator This should
have a comfortable head/chin rest, and two red
ﬁxation lights 15 degrees left and right of centre.
The ﬁxation lights should be bright when the light
adapting background is on, and as dim as practical
in the dark.
Pre-adaptation The test subject should be in
stable indoor lighting for as long as possible
before the test, and should not be exposed to any
large changes in lighting (lighter/darker) during
this period, such as indirect ophthalmoscopy. As
near as is practical, the pre-test light exposure
should be the same for all test subjects.
Preparing the test subject Explain the proce-
dure including, ‘chin/head on rest/restraint in
stimulator, 15 min dark, 15 min light, ﬁxation
lights alternate in simple rhythmic manner, for
10 s each minute, when lights change, move eyes
in single sweep to next one, do not turn head, do
not anticipate the changes’. Practice the proce-
dure with the recording system on and coach the
subject if there is head movement, overshoot,
stepping, or anticipation.
Dark phase In total darkness for 15 min,
except for the dim ﬁxation lights, alternate the
ﬁxation lights every 1 s for 10 s every 1 min,
and record the resulting EOG potentials. The
test subject should remain looking into the
stimulator the whole time if possible, and
should be warned of the start of each measure-
ment sequence to ensure attention. The opera-
tor must have an instant view of the recordings
to check for patient compliance, and errors such
as overshoot.
Light phase Bring on the ganzfeld background
light of 100 photopic cd/m
2 . If necessary, bring
this on gradually over a short period (e.g. 20 s) for
patient comfort, especially in cases of photopho-
bia. Continue recording every 1 min as above.
Keep the test subject forward in the stimulator
bowl for the whole time and with eyes open.
This completes the procedure for the test
subject.
Measure the amplitude of the EOG Taking care
to remove the effects of overshoot (see Fig. 2 and
notes below) and stepped saccades, measure the
EOG amplitude in lV, either manually or by a
computer algorithm. Calculate the average of the
amplitudes in each 10 s trial.
Plot the change in the responses Plot the average
amplitude of the EOG in lV on a graph repre-
senting the 30 min of the test. Ignore any points
known to be incorrect (e.g. subject did not follow
the ﬁxation lights properly), and identify the
underlying curve (see notes) as in Fig. 3 (lower
panel).
Calculate the Arden ratio This is the ratio
between the peak and trough of the underlying
curve, not the maximum and minimum recorded
values.
Report As a basic factual report state the
Arden ratio, the ﬁrst (dark) trough amplitude in
lV, the time from start of the light phase to the
peak (if present), the pupil size, and the type of
adapting light source. The report should also state Fig. 1 (a and b). Recording electrode positions
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the test session which may affect conﬁdence in the
results, such as the test subject’s difﬁculty in
performing the test.
Deviation from the Standard
This Standard represents a basic or core proce-
dure. If a laboratory chooses a procedure which
varies from the Standard Method above, it is
critical to cite this Standard, but specify the
deviations from the Standard Method, such as
different luminance level for the adapting light. If
a statistical report is given, then this must be
supported by reference data obtained under the
same conditions.
Additional tests
Some centres measure the ‘Fast Oscillation’
(FO), often in conjunction with the Clinical
EOG.
The fast oscillations:
The fast oscillations (FOs) have the opposite
polarity to the light rise of the Standard Clinical
EOG. At light onset there is a decrease in the
standing potential that recovers 30–40 s after light
onset. This decrease, the ‘light-trough’ (LT), is
caused by a decrease in intracellular Cl
- that
results in a decrease of Cl
- transport across the
Fig. 2 Idealised saccadic
recording with d.c.
ampliﬁer (top) and
example a.c. coupled
ampliﬁer with high pass
ﬁlter at 0.5 Hz and
0.1 Hz. Overshoot is hard
to recognise using 0.5 Hz
Fig. 3 Idealised (underlying) EOG response (top) and
practical response with noise and trial/trial variability.
Arrows show the dark trough (DT) and light peak (LP).
The underlying curve must be estimated before recording
the Arden ratio (LP/DT)
208 Doc Ophthalmol (2006) 113:205–212
123basolateral membrane resulting in a hyperpolar-
isation of the RPE basal membrane.
The FO is recorded using the same parameters
as for the clinical EOG (ampliﬁcation, electrode
placement and stimulus light intensity). However,
recordings should be made continuously as the
subject executes regular horizontal saccades at
1/s. Alternating light and dark for 60 s each
induces the FOs, which have a near sinusoidal
appearance. During the light interval a light
trough (LT) develops and begins to rise again
after 30–40 s. The subsequent interval of darkness
results in a dark rise (DR) at 30–40 s following
the onset of darkness. The next interval of light
induces another light trough. The total number of
light-dark intervals should be at least 4 with 60 s
periods of light and dark, making a total test time
of 8 min. Pre-adaptation does not affect the FO,
and so this test can be performed either indepen-
dently or in conjunction with the clinical EOG,
provided pre-adaptation conditions for the latter
are consistent within the lab.
Figure 4 shows a schematic idealised represen-
tation of the FO cycle, from which the ratio of
DP:LT should be reported. The normal ampli-
tude ratio is typically between 1.05 and 1.30.
However, at present each laboratory should
obtain and use their own reference data. It
should be noted that high blood glucose levels
increase the FO amplitudes.
Practical notes, instruments and deﬁnitions
(alphabetical)
Ampliﬁers For a 30 degree saccade, the typical
EOG amplitudes are between 250 and 1000 lV
with essential frequency content of 0 to 30 Hz.
With such signal amplitudes, no special shielding
nor interference protection should be necessary.
Medical grade ampliﬁers intended for human
physiological recording are required to be ‘elec-
trically isolated’ to prevent any risk of electric
shock to the patient via the recording electrodes.
Laboratory grade ampliﬁers may not have this
protection. To obtain recordings of saccadic
movements as a ‘square wave’ (the ideal) requires
a d.c. ampliﬁer (i.e. no high pass ﬁlter) but there
are operational penalties in terms of base line
shift due to electrode polarisation and movement,
which can be partially eliminated by the use a
high pass ﬁlter (e.g. 0.1 Hz). If a higher frequency
is used (e.g. 0.5 Hz) there is considerable ‘droop’
of the square wave, making identiﬁcation of
overshoot and stepped saccades more difﬁcult
(see Fig. 2). For the low pass ﬁlter, 30 Hz is
sufﬁcient. Including higher frequencies adds noise
to the response (e.g. EMG) and since most
automatic cursor placement regimes ﬁnd the
lowest and highest parts of the wave, this exag-
gerates the recorded amplitudes. Since both the
peak and the trough amplitudes will be equally
exaggerated the Arden ratio will be underesti-
mated. For guidance on verifying ampliﬁer per-
formance, see reference [3].
Ampliﬁer saturation EOG potentials measured
during saccadic eye movements as in the Standard
Clinical Method can vary by about 5:1 in ampli-
tude between subjects, which, with the light rise,
may mean a total amplitude range of up to 15:1.
Thus, the operator must be able to see the
recordings of the saccades to ensure saturation
does not occur, and to adjust the ampliﬁer gain
settings accordingly.
Arden ratio Using the Standard clinical EOG
method described here, the Arden ratio is the
peak EOG amplitude occurring in the light phase,
divided by the minimum amplitude during the
dark phase. The peak and trough values must be
measured from the ‘underlying curve’ as shown
on Fig. 3, not from individual measurements.
Fig. 4 Idealised representation of fast oscillations (FO).
In the dark intervals (black bars) the standing potential
increases to a dark rise maximum (DR). Following light
onset the standing potential falls to a light trough (LT).
The FO ratio of the DR:LT standing potentials should be
recorded
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123Compliance of the patient Test subjects will
have difﬁculty performing the saccadic move-
ments if they do not have good central vision, or
suffer from diplopia or dysconjugate eye move-
ments, have nystagmus, are very young, or are
inﬁrm and are unable to take up the physical
positions required for the duration of the tests.
Some patients also suffer claustrophobia or fear
of the dark, and so the testing must be performed
in such a way as to minimise these fears. Real-
time view of the EOG potentials, and infrared
camera view of the patient’s eyes, are very useful
in ensuring full compliance. In most cases,
coaching under observation can remedy poor
co-operation. A common issue is the patient
closing eyes during the light phase, which can be
seen by a camera.
The cost of unreliable performance is that the
margins of error are widened. This does not mean
that no information can be gleaned. If the
suspected disorder is one with a clear test
outcome, it may be possible to make the diagnosis
on one or two reliable trials performed near the
time of the trough and the peak, to ensure that
there is indeed a light rise of some amplitude, or
not.
Diplopia Test subjects often ﬁnd the ﬁxation
lights too near for them to achieve convergence.
The subject may be advised to look between the
pair of images in cases of intractable diplopia.
Subjects with ocular motility problems are likely
to give unreliable results. If the suspected retinal
disorder is bilateral, it is acceptable to patch one
eye to perform the tests (see the notes on
interaction between eyes below).
Electrodes Recording the EOG is relatively
undemanding as regards the electrodes. These
should be relatively non-polarisable such as stan-
dard medical EEG or ECG electrodes, of a size
appropriate for attachment to the side of the
nose. If baseline drift is excessive, less polarisable
electrodes may be necessary.
Fixation targets These should be small, red, and
adjustable in brightness so that they can be seen
clearly by all subjects above the background
illumination, and to be dim (just visible to the
test subject) in darkness.
Full ﬁeld (Ganzfeld) stimulator This should be
as large as practicable to allow adequate distance
from eye to ﬁxation lights. It should have a chin
rest and forehead bar to ensure stable head
position, and it should have ﬁxation lights 15
degree each side of centre. The background
intensity should be stable and ‘visibly white’
(see notes on Light below).
Interaction between eyes The EOG potentials
from one eye will contaminate the response from
the other. This is approximately 15% with elec-
trodes placed on each side of the nose close to the
inner canthi, rising to about 40% as they come
close together and then touch (e.g. becoming a
common central electrode placed on the bridge of
the nose). This can give misleading results in cases
of an electrically inactive (e.g. total retinal
detachment), or absent eye, in which case the
defective eye appears to have the same Arden
ratio as for the fellow eye, albeit on a much
smaller apparent standing potential. More con-
fusing is when the eyes have similar standing
potentials but different Arden ratios. In these
cases, the measured Arden ratio from the better
eye is enhanced at the expense of that from the
weaker eye, which can in fact appear to have an
Arden ratio of less than 1.0, solely due to
interaction.
Light
Luminance For the light phase the luminance of
the full ﬁeld adapting light should be 100 photopic
cd/m
2 as measured with a photometer (photopic
ﬁlter) with a traceable calibration (see also notes
on pupil dilation below). The calibration of the
ganzfeld stimulator should be carried out period-
ically, e.g. once a year, and corrective action
applied (see ref [3] for guidance). Modest room
lighting may be turned on during the light phase
when the impact on the effective luminance in the
bowl should be negligible with the test subject
looking into the bowl.
Darkness The dark phase should take place in
total darkness, and the ﬁxation lights should be
dimmed to the minimum necessary to enable
ﬁxation.
Colour There are several possible sources of
adapting light such as tungsten, halogen, LED, and
ﬂuorescent. For a commercial recording system,
the type will be stated in the manufacturer’s
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123literature. Spectrally these are quite different, and
the spectra for tungsten and halogen also change
with brightness. This issue makes the deﬁnition of
a single Standard Method for recording the
clinical EOG difﬁcult at present, and therefore
all reports should state the type of light source
used. If the user has additional data, such as
colour temperature, or scotopic luminance, then
this should be stated.
Normative data/reference range At present
there is no standard international reference range
for the clinical EOG. With the introduction of
this Standard (The Standard Clinical EOG
Method 2006) there is a greater possibility of
developing and comparing normative data (see
notes on reporting).
Photophobia The EOG ‘light rise’ is a ‘trig-
gered’ response, and is assumed to start from the
onset of the light phase. Some test subjects will
ﬁnd the light too bright and it may be necessary to
bring the adapting light up gradually over, say, a
20-second period. If so, this variation should be
stated. If the adapting light is brought on very
slowly (e.g. minutes), the response is changed.
Plotting The average EOG amplitude calcu-
lated from each 10-second trial should be plotted
(see Fig. 3). The ﬁrst critical step is that the
underlying physiologic curve is recognised and
drawn for derivation of the trough and peak. This
may require a curve ﬁtting algorithm or a tradi-
tional ‘ﬂexicurve’ (curve ﬁtting ruler) on paper.
Only then should the Arden ratio be calculated. It
is helpful if any uncertain values have been
identiﬁed and marked at the time of recording,
so that they can be ignored when identifying the
underlying curve.
Pupil dilation Having dilated pupils means less
variability in the light entering the eye. There
may be occasions when full pupil dilation is
impossible or undesirable. If pupils are not
artiﬁcially dilated, then the report should state
this. An attempt should be made to adjust the
adapting luminance to accommodate smaller or
variable pupils, and this luminance should be
quoted (it is usual to try to achieve the same value
in Trolands, as for dilated pupils). In many cases
useful diagnostic information can be obtained
without dilated pupils, especially with extreme
results (no light rise, strong light rise). Interme-
diate results for the Arden ratio will obviously be
of less value with undilated and therefore variable
pupil sizes.
Reporting
Basic factual report This should include the Arden
ratio, the ﬁrst (dark) trough amplitude in lV, the
time from the start of the light phase to the light
peak (if present), the pupil size at the end of the
test, and the type of adapting light source.
Statistical report This should show how the
calculated Arden ratio relates to a quoted refer-
ence range. If the reference range was obtained
with any different test parameters, this should be
explained.
No fully authenticated normal reference data is
available currently for the Standard Clinical EOG
method given above. However, from a review of
existing published data, Arden ratios <1.5 are
reported as being abnormally low, and those >2.0
are reported as probably normal, and in between
as borderline. This guidance may be useful in the
absence of local normative data, but the values do
not constitute validated diagnostic criteria.
Saccade measurement Use a scale or electronic
calliper to measure the change in EOG potential
resulting from each saccade, and calculate an
average for each 10 second trial. The average
should include only those measurements judged
to be reliable. Alternative measurement methods
may be used, including computer algorithms.
If a computer algorithm is used there is a need
to ensure that the values returned properly
represent the true EOG amplitudes. Each algo-
rithm is likely to make some mistakes. Fortu-
nately, the ﬁnal dark/light response curve will
form an ‘average of averages’ in which the
inﬂuence of a few errors should be swamped by
the remaining data.
Particular causes of unreliability are overshoot
(see Fig. 2), stepped saccades, missing saccades,
inverse saccades (eyes go opposite way to ﬁxation
lights), and eccentric ﬁxation in which the saccade
length switches between two or more values.
When measuring manually, these difﬁculties are
fairly obvious.
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123Standing potentials This Standard recommends
the reporting of the minimum standing potential
(dark trough minimum), taken from the underly-
ing response curve, not the minimum recorded
value. This value is not often used in diagnosis at
present, but if the value is abnormally low it may
indicate an inactive retina (e.g. total retinal
detachment), and the calculated Arden ratio
may be unreliable because of the low value of
the divisor in the ratio. Normal values for the
minimum standing potential should be estab-
lished, but as a guide, minimum standing poten-
tials less than 150 lV should be treated as low,
and more likely to produce unreliable Arden
ratios.
Warning of start of each trial There should be a
warning, verbal or automatic, of the impending
start of each trial, to ensure readiness of both test
subject and operator. Some users have sounds
(beeps) to co-incide with the alternations of the
ﬁxation lights. However, it may be better to rely
solely on the visual stimuli, to avoid the possibil-
ity of alternation without actual ﬁxation.
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